CD1530 是一种选择性的RARγ激动剂，其Kd为150 nM。CD1530 联合bexarotene 用于抑制致癌物4-硝基喹啉 1-氧化物诱导的人类口腔和食管鳞状细胞癌小鼠模型中口腔癌的发生。

CD1530 is a selective RARγ agonist with an Kd of 150 nM [1]. CD1530 in combination with bexarotene inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma [2].

107430-66-0

C27H26O3

398.49

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years